The NF-κB signaling pathway, a central component of the inflammation-fibrosis-cancer axis, is implicated not only in inflammatory diseases but also in pathological states where inflammation serves as a fundamental factor, such as in various forms of cancer (Czauderna et al., 2019; Zhao et al., 2023). The gene discussed is NFKB1; the disease is cancer.